Rheumatoid arthritis (RA) is an autoimmune disease that affects millions worldwide and can have a devastating impact on patients' lives. Yet, about one in three patients respond poorly to existing ...

Please provide your email address to receive an email when new articles are posted on . Rosnilimab depletes pathogenic T cells in patients with RA. Patient-reported data showed clinically important ...

CHICAGO -- An investigational monoclonal antibody drug targeting the PD-1 ligand on T cells was a winner in a phase II rheumatoid arthritis (RA) trial. Twelve weeks of treatment with the agent, called ...

After spending years tracing the origin and migration pattern of an unusual type of immune cell in mice, researchers have shown in a new study how activity of "good" microbes in the gut is linked to ...

Cedars-Sinai investigators may have figured out why certain immunosuppressive treatments don't work well in rheumatoid arthritis. In a study published in Science Immunology, scientists trace the ...

Millions of people around the world have an autoimmune disorder known as rheumatoid arthritis (RA), which can cause serious joint pain, swelling, and damage, among other symptoms. The disease is ...

Adaptive Biotechnologies said on Monday it has signed two non-exclusive deals with Pfizer to support research in rheumatoid ...